Compare TECH & DPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | DPZ |
|---|---|---|
| Founded | 1976 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 10.3B |
| IPO Year | 1995 | 2004 |
| Metric | TECH | DPZ |
|---|---|---|
| Price | $72.68 | $322.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 30 |
| Target Price | $70.50 | ★ $356.48 |
| AVG Volume (30 Days) | ★ 2.7M | 807.0K |
| Earning Date | 11-17-2026 | 10-13-2026 |
| Dividend Yield | 0.44% | ★ 2.47% |
| EPS Growth | ★ 152.17 | 5.27 |
| EPS | 1.16 | ★ 12.80 |
| Revenue | $1,215,039,000.00 | ★ $4,939,994,000.00 |
| Revenue This Year | $4.38 | $5.00 |
| Revenue Next Year | $10.06 | $1.65 |
| P/E Ratio | $62.65 | ★ $25.15 |
| Revenue Growth | N/A | ★ 4.96 |
| 52 Week Low | $43.20 | $282.00 |
| 52 Week High | $72.75 | $442.35 |
| Indicator | TECH | DPZ |
|---|---|---|
| Relative Strength Index (RSI) | 57.86 | 57.50 |
| Support Level | $72.11 | $297.56 |
| Resistance Level | $72.75 | $326.85 |
| Average True Range (ATR) | 0.11 | 7.57 |
| MACD | -0.00 | 1.70 |
| Stochastic Oscillator | 80.00 | 84.62 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Domino's is the world's largest pizza chain, surpassing $20 billion in system sales with over 22,100 stores across more than 90 markets at the end of 2025. Around 33% of its units are in the US. The business is 99% franchised. Domino's operates through three segments: supply chain (60% of revenue), US stores (33%), and international franchises (7%). The firm generates the bulk of its revenue by supplying food to stores in the US and Canada through a vertically integrated network of 25 manufacturing and supply chain facilities, which primarily produce and distribute dough, and by collecting brand royalties and marketing fees from franchisees. Domino's also generates revenue from sales at company-owned stores.